Fabio Cocco

Fabio Cocco

Auto-generated profile, based on publicly available information

Fabio Cocco

Dipartimento di Chimica, Università degli Studi di Sassari, Via Vienna 2, I-07100 Sassari, Italy

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 July 2013 in Nutrients
Verified
Journal Article
Open access
Maria Grazia CagettiMaria Grazia Cagetti
Maria Grazia Cagetti
SMStefano Mastroberardino
Stefano Mastroberardino
Egle MiliaEgle Milia
Egle Milia
FCFabio Cocco
Fabio Cocco
PLPeter Lingström
Peter Lingström
Guglielmo CampusGuglielmo Campus
Guglielmo Campus
This paper aims to provide a systematic review of the caries-prevention effect of probiotics in human. The hypothesis was that the administration of probiotic strains might play a role in caries lesion prevention and in the control of caries-related risk factors. The main relevant databases (Medline, Embase) were searched. Quality of the Randomized Clinical Trials (RCTs) was classified using the “Consolidated Standards of Reporting Trials” (CONSORT) checklist and the Impact Factor (IF) value of each journal was recorded. Sixty-six papers were identified, and 23 fulfilled the inclusion criteria. Only three studies had caries lesion development as outcome, all the others reported caries risk factors as interim evaluation. Using the CONSORT Score, the papers were coded as 4 excellent, 9 good and 10 poor. The mean IF value recorded was 1.438. Probiotics may play a role as antagonistic agent on mutans streptococci (MS), acidogenic/aciduric bacteria that contributes to the caries process. In two-thirds of the selected papers, probiotics have demonstrated the capacity to reduce MS counts in saliva and/or plaque in short-term. The effect of probiotics on the development of caries lesion seems encouraging, but to date, RCTs on this topic are insufficient to provide scientific clinical evidence.

25 October 2005 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
MCMaria A. Cinellu
Maria A. Cinellu
GMGiovanni Minghetti
Giovanni Minghetti
FCFabio Cocco
Fabio Cocco
SSSergio Stoccoro
Sergio Stoccoro
Antonio ZuccaAntonio Zucca
Antonio Zucca
MMMario Manassero
Mario Manassero

16 July 2018 in BMC Oral Health
Verified
Journal Article
Open access
PDF file
Maria Grazia CagettiMaria Grazia Cagetti
Maria Grazia Cagetti
GBGiuliana Bontà
Giuliana Bontà
FCFabio Cocco
Fabio Cocco
PLPeter Lingstrom
Peter Lingstrom
LSLaura Strohmenger
Laura Strohmenger
Guglielmo CampusGuglielmo Campus
Guglielmo Campus
Assessing caries risk is an essential element in the planning of preventive and therapeutic strategies. Different caries risk assessment (CRA) models have been proposed for the identification of individuals running a risk of future caries. This systematic review was designed to evaluate whether standardized caries risk assessment (CRA) models are able to evaluate the risk according to the actual caries status and/or the future caries increment. Randomized clinical trials, cross-sectional studies, cohort studies, comparative studies, validation studies and evaluation studies, reporting caries risk assessment using standardized models (Cariogram, CAMBRA, PreViser, NUS-CRA and CAT) in patients of any age related to caries data recorded by DMFT/S or ICDAS indices, were included. PubMed, Scopus and Embase were searched from 2000 to 2016. A search string was developed. All the papers meeting the inclusion criteria were subjected to a quality assessment. One thousand three-undred ninety-two papers were identified and 32 were included. In all but one, the Cariogram was used both as sole model or in conjunction with other models. All the papers on children (n = 16) and adults (n = 12) found a statistically significant association between the risk levels and the actual caries status and/or the future caries increment. Nineteen papers, all using the Cariogram except one, were classified as being of good quality. Three of four papers comprising children and adults found a positive association. For seven of the included papers, Cariogram sensibility and specificity were calculated; sensibility ranged from low (41.0) to fairly low (75.0), while specificity was higher, ranging from 65.8 to 88.0. Wide 95% confidence intervals for both parameters were found, indicating that the reliability of the model differed in different caries risk levels. The scientific evidence relating to standardized CRA models is still limited; even if Cariogram was tested in children and adults in few studies of good quality, no sufficient evidence is available to affirm the method is effective in caries assessment and prediction. New options of diagnosis, prognosis and therapy are now available to dentists but the validity of standardized CRA models still remains limited.

2 October 2006 in Dalton Transactions
Verified
Journal Article
Closed access
PDF file
MCMaria A. Cinellu
Maria A. Cinellu
GMGiovanni Minghetti
Giovanni Minghetti
FCFabio Cocco
Fabio Cocco
SSSergio Stoccoro
Sergio Stoccoro
Antonio ZuccaAntonio Zucca
Antonio Zucca
MAMassimiliano Arca
Massimiliano Arca
Unprecedented 16-electron gold(I) olefin complexes of general formula [Au(bipyR,R′)(η2-olefin)](PF6) and [Au2(bipyR,R′)2(µ-η2:η2-diolefin)](PF6)2 (bipyR,R′ = 6-substituted-2,2′-bipyridine) have been prepared by reaction of dinuclear gold(III) oxo complexes [Au2(bipyR,R′)2(µ-O)2](PF6)2 with the appropriate olefin. The X-ray crystal structures of two mononuclear complexes (olefin = styrene) show in-plane coordination of the olefin and a CC bond distance considerably lengthened with respect to the free olefin. The spectroscopic properties of the complexes are discussed and compared with those of analogous d10 metal derivatives. Both structural and spectroscopic information indicate a substantial contribution of π-back-donation to the Au–olefin bond in the three-coordinate species. Theoretical calculations carried out at the hybrid-DFT level on the model compound [Au(bipy)(η2-CH2 CH2)]+ show excellent agreement with the experimental findings giving in addition an estimate of a π-back-bonding contribution higher than that of the σ-bonding.

26 May 2015 in Dalton Transactions
Verified
Journal Article
Open access
PDF file
BBBenoît Bertrand
Benoît Bertrand
SSSarah Spreckelmeyer
Sarah Spreckelmeyer
EBE. Bodio
E. Bodio
FCF. Cocco
F. Cocco
MPM. Picquet
M. Picquet
ACAngela Casini
Angela Casini
A series of novel (C^N) cyclometallated Au(III) complexes of general formula [Au(pyb-H)L1L2]n+ (pyb-H = C^N cyclometallated 2-benzylpyridine, L1 and L2 being chlorido, phosphane or glucosethiolato ligands, n = 0 or 1) have been synthesized and fully characterized using different techniques, including NMR, IR and far-IR, mass spectrometry, as well as elemental analysis. The crystal structure of one compound has been solved using X-ray diffraction methods. All compounds were tested in vitro in five human cancer cell lines including the lung, breast, colon and ovarian cancer cells. For comparison purposes, all compounds were also tested in a model of healthy human cells from the embryonic kidney. Notably, all new compounds were more toxic than their cyclometallated precursor bearing two chlorido ligands, and the derivative bearing one phosphane ligand presented the most promising toxicity profile in our in vitro screening, displaying a p53 dependent activity in colorectal cancer HCT116 cells. Finally, for the first time C^N cyclometallated gold(III) complexes were shown to be potent inhibitors of the zinc finger protein PARP-1, involved in the mechanism of cisplatin resistance.

5 May 2013 in Clinical Oral Investigations
Verified
Journal Article
Open access
PDF file
Guglielmo CampusGuglielmo Campus
Guglielmo Campus
FCFabio Cocco
Fabio Cocco
GCGiovanna Carta
Giovanna Carta
MCMaria Grazia Cagetti
Maria Grazia Cagetti
CSCharlotte Simark-Mattson
Charlotte Simark-Mattson
PLPeter Lingström
Peter Lingström
Objectives A double-blind, randomised, placebo-controlled clinical trial was performed to validate the hypothesis that the use of lozenges containing Lactobacillus brevis CD2 (Inersan®, CD Investments srl) may reduce plaque pH, salivary mutans streptococci (ms) and bleeding on probing, during a 6-week period, in a sample of high caries risk schoolchildren. Methods A total of 191 children (aged 6–8 years), presenting two to three carious lesions and a salivary ms concentration of ≥105 CFU/ml, were enrolled and divided into two groups, an L. brevis CD2 lozenge group and a no L. brevis lozenge group, and examined at baseline (t0), after 3 weeks (t1), after 6 weeks of lozenge use (t2) and 2 weeks after the cessation of lozenge use (t3). Plaque pH was assessed using the microtouch technique following a sucrose challenge. The area under the curve (AUC5.7 and AUC6.2) was recorded. Salivary ms were counted, and bleeding on probing was assessed. Results At t0, the plaque-pH and ms concentration values were similar in both groups. Mean areas (AUC5.7 and AUC6.2) were significantly greater in the control group at t1, t2 and t3. L. brevis CD2 lozenges significantly reduced salivary ms concentrations and bleeding. The subjects from the test group showed a statistically significant decrease (p = 0.01) in salivary ms concentration. At t2, a statistically significantly lower bleeding value was recorded in the test group compared with the control group (p = 0.02). Conclusions Six weeks’ use of lozenges containing L. brevis CD2 had a beneficial effect on some important variables related to oral health, including a reduction in plaque acidogenicity, salivary ms and bleeding on probing. (Trial Registration Number NCT01601145 08/21/2012)